A5072782837- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Clinical practice guidelines implementation
- Genetic factors in colorectal cancer
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Advanced Radiotherapy Techniques
- Radiopharmaceutical Chemistry and Applications
- Breast Cancer Treatment Studies
- Advanced Breast Cancer Therapies
- Gastric Cancer Management and Outcomes
- Cancer, Lipids, and Metabolism
- Colorectal Cancer Screening and Detection
- Genital Health and Disease
- Colorectal and Anal Carcinomas
- Urologic and reproductive health conditions
- Esophageal Cancer Research and Treatment
- Cancer Genomics and Diagnostics
- PARP inhibition in cancer therapy
- Urological Disorders and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- HER2/EGFR in Cancer Research
- Renal and related cancers
American Society of Clinical Oncology
2015-2025
Cornell University
2018-2023
Helios Hospital Schwerin
2023
Yale Cancer Center
2022
Memorial Sloan Kettering Cancer Center
2014-2018
UNC Lineberger Comprehensive Cancer Center
2018
Juravinski Cancer Centre
2018
University of North Carolina at Chapel Hill
2018
Durham VA Medical Center
2018
University of Pennsylvania
2018
To develop recommendations about endocrine therapy for women with hormone receptor (HR) -positive metastatic breast cancer (MBC).The American Society of Clinical Oncology convened an Expert Panel to conduct a systematic review evidence from 2008 through 2015 create informed by that evidence. Outcomes interest included sequencing hormonal agents, agents compared chemotherapy, targeted biologic therapy, and treatment premenopausal women. This guideline puts forth as HR-positive MBC.Sequential...
Purpose To endorse Cancer Care Ontario’s guideline on Active Surveillance for the Management of Localized Prostate Cancer. The American Society Clinical Oncology (ASCO) has a policy and set procedures endorsing clinical practice guidelines developed by other professional organizations. Methods was reviewed developmental rigor methodologists. ASCO Endorsement Panel then content recommendations. Results determined that recommendations from guideline, published in May 2015, are clear, thorough,...
To identify optimal chemo- and targeted therapy for women with human epidermal growth factor 2 (HER2)- negative (or unknown) advanced breast cancer.
To endorse the European Association of Urology guideline on muscle-invasive (MIBC) and metastatic bladder cancer. The American Society Clinical Oncology (ASCO) has a policy set procedures for endorsing clinical practice guidelines that have been developed by other professional organizations.The MIBC cancer was reviewed developmental rigor methodologists. ASCO Endorsement Panel then content recommendations.The determined recommendations from cancer, published online in March 2015, are clear,...
In April 2017, the American Urological Association, Society for Radiation Oncology, and of Urologic Oncology released a joint evidence-based practice guideline on clinically localized prostate cancer. The Clinical (ASCO) has policy set procedures endorsing clinical guidelines that have been developed by other professional organizations.The Clinically Localized Prostate Cancer was reviewed developmental rigor methodologists. An ASCO Expert Panel then content recommendations.The determined...
Abstract Objective Data extraction from the published literature is most laborious step in conducting living systematic reviews (LSRs). We aim to build a generalizable, automated data workflow leveraging large language models (LLMs) that mimics real-world 2-reviewer process. Materials and Methods A dataset of 10 trials (22 publications) LSR was used, focusing on 23 variables related trial, population, outcomes data. The split into prompt development (n = 5) held-out test sets 17)....
Purpose To jointly update the Cancer Care Ontario guideline on brachytherapy for patients with prostate cancer to account new evidence. Methods An Update Panel conducted a targeted systematic literature review and identified more recent randomized controlled trials comparing dose-escalated external beam radiation therapy (EBRT) in men cancer. Results Five provided evidence this update. Recommendations For low-risk who require or choose active treatment, low–dose rate (LDR) alone, EBRT and/or...
Objectives.— To develop evidence-based guideline recommendations through a systematic review of the literature to establish standard molecular biomarker testing colorectal cancer (CRC) tissues guide epidermal growth factor receptor (EGFR) therapies and conventional chemotherapy regimens. Methods.— The American Society for Clinical Pathology, College Pathologists, Association Molecular Oncology convened an expert panel patients with CRC. A comprehensive search that included more than 4,000...
Context.— A complete diagnosis of acute leukemia requires knowledge clinical information combined with morphologic evaluation, immunophenotyping and karyotype analysis, often, molecular genetic testing. Although many aspects the workup for are well accepted, few guidelines have addressed different diagnostic evaluation samples from patients suspected to leukemia. Objective.— To develop a guideline treating physicians pathologists involved in prognostic new samples, including lymphoblastic...
PURPOSE Update all preceding ASCO guidelines on initial hormonal management of noncastrate advanced, recurrent, or metastatic prostate cancer. METHODS The Expert Panel based recommendations a systematic literature review. Recommendations were approved by the and Clinical Practice Guidelines Committee. RESULTS Four clinical practice guidelines, one endorsement, 19 reviews with without meta-analyses, 47 phase III randomized controlled trials, nine cohort studies, two review papers informed...
ASCO Rapid Recommendations Updates highlight revisions to select guideline recommendations as a response the emergence of new and practice-changing data. The rapid updates are supported by an evidence review follow development processes outlined in Guideline Methodology Manual. goal these articles is disseminate updated recommendations, timely manner, better inform health practitioners public on best available cancer care options.